Why Did Calidi Biotherapeutics Stock Plunge 10.55%?

On July 28, 2025, Calidi's stock experienced a significant drop of 10.55% in pre-market trading, marking a notable decline in its share price.

Calidi Biotherapeutics has announced a reverse stock split, which is expected to take effect on August 5, 2025. This 1-for-12 split will adjust the trading basis of the company's shares, potentially impacting investor holdings and market perception.

The reverse stock split is a strategic move by Calidi to increase the per-share price, which could attract institutional investors and improve liquidity. This decision reflects the company's efforts to enhance its financial profile and market standing.

Investors and analysts are closely monitoring the impact of this reverse stock split on Calidi's stock performance. The move is seen as a proactive measure to address potential market concerns and stabilize the company's share price in the long term.